Primary care provider attitudes about and tendency to use non-recommended surveillance tests after curative breast cancer treatment
Supporting Files
-
8 2023
-
File Language:
English
Details
-
Alternative Title:Breast Cancer Res Treat
-
Personal Author:
-
Description:Purpose:
Little is known about factors contributing to receipt of non-recommended surveillance testing among early-stage breast cancer survivors. We assessed primary care providers (PCP) attitudes about and tendency to order non-recommended surveillance testing for asymptomatic early-stage breast cancer survivors post-adjuvant chemotherapy.
Methods:
A stratified random sample of PCPs identified by early-stage breast cancer survivors were surveyed (N=518, 61% response rate). PCPs were asked how likely they would be to order bone scans, imaging and/or tumor marker testing using a clinical vignette of an early-stage asymptomatic patient where these tests are non-recommended. A composite tendency to order score was created and categorized by tertiles (low, moderate, high). PCP-reported factors associated with high and moderate tendency to order non-recommended testing (vs. low) were estimated using multivariable, multinomial logistic regression.
Results:
In this sample, 26% reported a high tendency to order non-recommended surveillance tests during survivorship for early-stage breast cancer survivors. PCPs who identified as family practice physicians and PCPs reporting more confidence in ordering surveillance testing were more likely to report a high tendency to order non-recommended testing (vs. low) ((aOR family practice 2.09, CI 1.2, 3.8; aOR more confidence 1.9, CI 1.1, 3.3).
Conclusions:
In this population-based sample of PCPs caring for breast cancer survivors, over a quarter of PCPs reported they would order non-recommended surveillance testing for asymptomatic early-stage breast cancer survivors. Efforts to better support PCPs and disseminate information about appropriate surveillance for cancer survivors are warranted.
-
Subjects:
-
Keywords:
-
Source:Breast Cancer Res Treat. 200(3):391-398
-
Pubmed ID:37296280
-
Pubmed Central ID:PMC10706825
-
Document Type:
-
Funding:P30 CA046592/CA/NCI NIH HHSUnited States/ ; P01CA163233/CA/NCI NIH HHSUnited States/ ; T32-CA-236621/CA/NCI NIH HHSUnited States/ ; T32 CA236621/CA/NCI NIH HHSUnited States/ ; U58 DP003862/DP/NCCDPHP CDC HHSUnited States/ ; P01 CA163233/CA/NCI NIH HHSUnited States/ ; U58 DP003875/DP/NCCDPHP CDC HHSUnited States/
-
Volume:200
-
Issue:3
-
Collection(s):
-
Main Document Checksum:urn:sha-512:29ad310b347a983e7b8952ea5db9fd133feda0be461b01c97b33433458ba3f193a79b2bf139326e51900a042a99e278d2759206c8ddae304cd0c393bedd7373f
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access